BEX3
Protein BEX3
Also known as: Bex, BEX3_HUMAN, DXS6984E, HGR74, NADE, NGFRAP1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q00994
- Gene
- BEX3
- Ensembl
- ENSG00000166681
- Chromosome
- X
- Canonical length
- 111 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Enables identical protein binding activity. Predicted to be involved in negative regulation of protein ubiquitination and signal transduction. Predicted to act upstream of or within extrinsic apoptotic signaling pathway via death domain receptors. Located in cytosol. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
111 residues, UniProt reviewed canonical sequence.
>Q00994|BEX3
1 MANIHQENEE MEQPMQNGEE DRPLGGGEGH QPAGNRRGQA RRLAPNFRWA IPNRQINDGM
61 GGDGDDMEIF MEEMREIRRK LRELQLRNCL RILMGELSNH HDHHDEFCLM PLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BEX3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.65
- Highest tissue expression
- 830 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 830 nTPM
- hypothalamus: 662 nTPM
- cerebral cortex: 630 nTPM
- basal ganglia: 624 nTPM
- amygdala: 544 nTPM
- hippocampal formation: 531 nTPM
Single-cell type
- epididymal principal cells: 2,036 nCPM
- cytotrophoblasts: 1,864 nCPM
- migrating cytotrophoblasts: 1,467 nCPM
- platelets: 1,458 nCPM
- peritubular myoid cells: 973 nCPM
- granulosa cells: 886 nCPM
Immune cell
- naive CD4 T-cell: 151 nTPM
- T-reg: 138 nTPM
- memory CD4 T-cell: 72 nTPM
- naive CD8 T-cell: 71 nTPM
- total PBMC: 67 nTPM
- NK-cell: 29 nTPM
Brain region
- hypothalamus: 537 nTPM
- choroid plexus: 476 nTPM
- cerebral cortex: 357 nTPM
- hippocampal formation: 344 nTPM
- midbrain: 330 nTPM
- basal ganglia: 326 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.96
- gnomAD pLI
- 0.62
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- extrinsic apoptotic signaling pathway via death domain receptors
- negative regulation of protein ubiquitination
- regulation of apoptotic signaling pathway
- signal transduction
Molecular functions
- cysteine-type endopeptidase activator activity involved in apoptotic process
- identical protein binding
- metal ion binding
- molecular function inhibitor activity
- nerve growth factor receptor binding
- signaling receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BEX3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BEX3 as an antibody target. Whether an autoantibody or antibody against BEX3 could matter depends on whether native BEX3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BEX3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BEX3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...